JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways
Metabolic Enzyme/Protease

Metabolic Enzyme/Protease

B3265 Balicatib

Summary: Cathepsin K inhibitor

≥17 mg/mL
B2217 Clinofibrate

Summary: HMGCR inhibitor
B2213 Temocapril HCl

Summary: angiotensin-converting enzyme (ACE) inhibitor

insoluble in H2O; ≥13.25 mg/mL
B2212 Moexipril HCl

Summary: ACE inhibitor

≥52.2 mg/mL
B2211 Cilazapril Monohydrate

Summary: angiotensin-converting enzyme (ACE) inhibitor

Soluble in DMSO
B2209 Temocapril

Summary: angiotensin-converting enzyme (ACE) inhibitor

Soluble in DMSO
B2207 Quinapril HCl

Summary: angiotensin-converting enzyme (ACE) inhibitor

≥19.6 mg/mL
B2205 Enalapril Maleate

Summary: angiotensin-converting enzyme (ACE) inhibitor

≥23.15 mg/mL
B2202 Lisinopril

Target: Angiotensin-Converting Enzymes (ACEs)

Summary: angiotensin-converting enzyme (ACE) inhibitor

Soluble in DMSO
B2114 Mitoxantrone HCl
2 Citation

Target: Pim|Topoisomerases|USP|HIV Integrases

Summary: Topoisomerase II inhibitor, anti-neoplastic drug

insoluble in EtOH; ≥51.53 mg/mL